Evidence map›Paper›PMID 33145045›Full record

ArticleJournal of thoracic disease2020

Retrospective outcomes analysis of 99 consecutive uniportal awake lung biopsies: a real standard of care?

Roberto Cherchi, Giulia Grimaldi, Matteo Pinna-Susnik, Laura Riva, Sabrina Sarais, Massimiliano Santoru, Roberto Perra, Roberto Allieri, Giuseppe S Porcu, Sonia Nemolato and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of thoracic disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Yield and safety of different biopsy types in interstitial lung disease: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2026
    Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Roberto CherchiDivision of Thoracic Surgery, "A. Businco" Oncology Hospital, Azienda Ospedaliera Brotzu, Cagliari, Italy.
Giulia GrimaldiDivision of Thoracic Surgery, "A. Businco" Oncology Hospital, Azienda Ospedaliera Brotzu, Cagliari, Italy.
Matteo Pinna-SusnikDivision of Thoracic Surgery, "A. Businco" Oncology Hospital, Azienda Ospedaliera Brotzu, Cagliari, Italy.
Laura RivaDivision of Thoracic Surgery, "A. Businco" Oncology Hospital, Azienda Ospedaliera Brotzu, Cagliari, Italy.
Sabrina SaraisDivision of Thoracic Surgery, "A. Businco" Oncology Hospital, Azienda Ospedaliera Brotzu, Cagliari, Italy.
Massimiliano SantoruDivision of Thoracic Surgery, "A. Businco" Oncology Hospital, Azienda Ospedaliera Brotzu, Cagliari, Italy.
Roberto PerraPulmonology Unit and Respiratory Physiopathology Laboratory, "R. Binaghi" and "SS. Trinità" Hospitals, ATS Sardegna, Cagliari, Italy.
Roberto AllieriRadiology Service, "R. Binaghi" Hospital, ATS Sardegna, Cagliari, Italy.
Giuseppe S PorcuHistopathology Department, "A. Businco" Oncology Hospital, Azienda Ospedaliera Brotzu, Cagliari, Italy.
Sonia NemolatoHistopathology Department, "A. Businco" Oncology Hospital, Azienda Ospedaliera Brotzu, Cagliari, Italy.
Antonella MameliInternal Medicine and Haemocoagulopathies Division, AOU of Monserrato, Monserrato, Italy.
Federica LoiSardinian Epidemiological Observatory, IZS of Sardinia, Cagliari, Italy.
Paolo A FerrariDivision of Thoracic Surgery, "A. Businco" Oncology Hospital, Azienda Ospedaliera Brotzu, Cagliari, Italy.
Azienda Ospedaliera G. Brotzu · ITATS Sardegna (Italy) · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSurgical lung biopsy for interstitial lung disease (ILD) is traditionally performed through video-assisted thoracic surgery (VATS) and general anesthesia (GA). The mortality and morbidity rates associated with this procedure are not negligible, especially in patients with significant risk factors and respiratory impairment. Based on these considerations, our center evaluated a safe non-intubated VATS approach for lung biopsy performed in ILD subjects.

methodsNinety-nine patients affected by undetermined ILD were enrolled in a retrospective cohort study. In all instances, lung biopsies were performed using a non-intubated VATS technique, in spontaneously breathing patients, with or without intercostal nerve blockage. The primary end-point was the diagnostic yield, while surgical and global operating room times, post-operative length of stay (pLOS), numeric pain rating scale (NPRS) after surgery and early mortality were considered as secondary outcomes.

resultsAll the procedures were carried out without conversion to GA. The pathological diagnosis was achieved in 97 patients with a diagnostic yield of 98%. The mean operating room length-of-stay and operating time were 73.7 and 42.5 min, respectively. Mean pLOS was 1.3 days with a low readmissions rate (3%). No mortality in the first 30 days due to acute exacerbation of ILD occurred. Both analgesia methods resulted in optimal feasibility with a mean NPRS score of 1.13.

conclusionsIn undetermined ILD patients, surgical lung biopsy with a non-intubated VATS approach and spontaneous ventilation anesthesia appears to be both a practical and safe technique with an excellent diagnostic yield and high level of patient satisfaction.

Indexed as

Awake surgeryinterstitial lung disease (ILD)non-intubated video-assisted thoracic surgery (NIVATS)surgical lung biopsy (SLB)tubeless anesthesia

Identifiers

PMID33145045
PMCPMC7578489
OpenAlexW3049229740

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.